• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: CPI - DEL CARIBE ENDOTAK RELIANCE; IMPLANTABLE LEAD

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

CPI - DEL CARIBE ENDOTAK RELIANCE; IMPLANTABLE LEAD Back to Search Results
Model Number 0185
Device Problems High impedance (1291); Pocket Stimulation (1463); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Muscle Stimulation (1412); Fatigue (1849); Burning Sensation (2146); Complaint, Ill-Defined (2331)
Event Date 12/22/2016
Event Type  Injury  
Manufacturer Narrative
Upon receipt at our post market quality assurance laboratory, only the proximal segment of the lead was returned.The lead was severed 19.6 centimeters (cm) from the is-1 terminal pin.Set screw marks were noted on all terminal connectors in the correct location.Resistance and pressure tests were completed to assess lead electrical performance and insulation integrity of the returned lead segment.Measurements throughout these tests were within normal limits.Laboratory testing of the returned lead segment was unable to reproduce the reported clinical observations and detailed analysis did not reveal any abnormalities.Laboratory analysis did not identify any lead characteristics that would have caused or contributed to the reported clinical observations.
 
Event Description
Boston scientific received information that the patient with this right ventricular (rv) defibrillation lead presented to the emergency room (er) due to heating/warmth sensations in the throat and pocket during pacing.The shock impedance measurements had been trending up, and were subsequently greater than 200 ohms.The patient also had flushing on the left-sided neck area.Their neck was distended, and the patient had pulsations and tremors on the left pectoral, which could not be recreated upon troubleshooting.The patient also reported feeling sluggish.Lead diagnostics were performed and the patient felt every ventricular pace.The rv pacing impedance measurement was 682 ohms and consistent.A surgical revision was performed; the lead was partially abandoned, and a portion of the lead was returned for analysis.A new system was implanted on the patient¿s right side.It was suspected that the patient had subclavian syndrome.Additional information was received which indicated that during the revision, this rv lead was tested via the pacing system analyzer (psa) and still showed high shock impedance measurements.There was no visible injury to the rv lead.The physician chose to replace the lead and utilize the same device.The system was tested during the pre-discharge check and was noted to be fine.No additional adverse patient effects were reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENDOTAK RELIANCE
Type of Device
IMPLANTABLE LEAD
Manufacturer (Section D)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer (Section G)
CPI - DEL CARIBE
guidant puerto rico b. v.
dorado PR
Manufacturer Contact
sonali vasekar
4100 hamline ave. n
st. paul, MN 
6515824786
MDR Report Key6281066
MDR Text Key65864873
Report Number2124215-2017-01398
Device Sequence Number1
Product Code LWS
Combination Product (y/n)N
PMA/PMN Number
P910073/S043
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Physician
Type of Report Initial
Report Date 12/22/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/26/2017
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Expiration Date06/27/2009
Device Model Number0185
Other Device ID NumberENDOTAK RELIANCE G
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer01/03/2017
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Manufacturer Received12/22/2016
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/27/2007
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
0185; 4136; D023; T175
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age61 YR
-
-